Aveanna Healthcare Holdings Inc. (AVAH) - Stock Analysis

Last updated: Sep 19, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Healthcare services hot idea with earnings and guidance support: Q2 revenue rose 13.7% YoY to $670.5M, net income improved to $40.3M, adjusted EBITDA reached $95.4M, and management lifted 2026 revenue and EBITDA guidance; shares broke out on 2026-08-13/14 and gained about 29% over 21 trading days.

Loading chart data...

Idea window: 8/17/2026 – 8/24/2026Sector: Healthcare

AI Analyst Overview

Last Price
$13.44
Market Cap
$2.93B
1D Return
-1.68%
YTD Return
+64.50%

Loading chart data...

Valuation Metrics

P/E
10.1
P/B
10.2
P/S
1.1
EV/EBITDA
14.7
Div Yield
—

Fundamental Analysis

5.0

Key Financial Insights: • Margin Expansion • High Leverage • Liquidity Pressure AVAH shows improving profitability and cash generation, but high debt, weakening liquidity, intangible-heavy assets, and richer valuation warrant caution.

Profitability
Leverage

Price Behavior

6.0

Key Price Behavior Insights: • Fading Momentum • Key Support • Breakout Trigger Support Level: $13.58–$13.64 Resistance Level: $14.26–$14.38 AVAH remains modestly bullish over the last month, but fading momentum below $13.70 makes holding $13.58–$13.64 support key, while a move above $14.26–$14.38 would renew upside.

AVAH
TechnicalAnalysis

Sentiment & News

7.0

Key News Insights: • Earnings Momentum • Institutional Buying • Deleveraging Focus Aveanna's strong earnings momentum, institutional buying, and growth strategy support a positive outlook, though leverage and secondary-share supply remain key watchpoints.

HealthcareGrowth
LeverageWatch
AI

AI Summary

6.0
Neutral

AVAH has evolved into a deleveraging execution story: sustained margin and free-cash-flow delivery—especially converting California reimbursement gains into staffed capacity—could justify further upside, but at ~$14–$15 the stock now requires visible debt reduction toward <3.0x leverage and reliable cash conversion to offset labor, reimbursement, and residual balance-sheet risk.

CaliforniaCatalyst
ExecutionRisk
Deleveraging
AI summary updated 2 days ago

Description

Aveanna Healthcare Holdings is a U.S. home-care services company that delivers private-duty nursing, home health and hospice care, pediatric therapy, and enteral nutrition through three operating segments. Its services include in-home skilled nursing and therapy, school- and clinic-based pediatric support, and periodic supply delivery, enabling many patients—particularly medically fragile children—to receive care outside hospital settings. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Aug 17Aug 24AVAHAveanna Healthcare Holdings Inc.
Healthcare services hot idea with earnings and guidance support: Q2 revenue rose 13.7% YoY to $670.5M, net income improved to $40.3M, adjusted EBITDA reached $95.4M, and management lifted 2026 revenue and EBITDA guidance; shares broke out on 2026-08-13/14 and gained about 29% over 21 trading days.
Closed+8.0%
Jun 23Jun 30AVAHAveanna Healthcare Holdings Inc.
Healthcare services name with improving fundamentals and clear catalysts: Q1 2026 revenue grew 15.9% to $647.9M, adjusted EBITDA rose 25.2%, full-year 2026 guidance was raised on 2026-05-14, and the Family First Homecare acquisition closed on 2026-06-02.
Closed+4.5%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.